-

Oxford Finance Closes $60 Million Credit Facility with RxSight

RxSight developed the first and only lens that can be customized after cataract surgery.

ALEXANDRIA, Va. & ALISO VIEJO, Calif.--(BUSINESS WIRE)--Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, has announced the closing of a $60 million senior secured term loan with RxSight, Inc. (“RxSight” or “the Company”), a privately-held, medical technology company that has commercialized the world’s first and only FDA-approved adjustable intraocular lens (“IOL”) that is customized after cataract surgery. The funds will be used for general working capital, including sales and marketing, and research and development.

The Company’s mission is to revolutionize the premium cataract surgery experience by allowing surgeons to partner with their patients to achieve optimized results for every unique eye. The RxSight® Light Adjustable Lens™ delivers superior visual outcomes—patients can now customize their vision after cataract surgery until it meets their personal desires and lifestyle requirements. This optimization is performed by an eye doctor after lens implantation through a series of office-based light treatment procedures that take only a few minutes each.

“RxSight’s proprietary Light Adjustable Lens offers an invaluable advancement in the cataract surgery market,” said Christopher A. Herr, senior managing director at Oxford Finance. “Oxford is happy to provide capital to support the Company’s innovative approach that enables optimization of vision specific to a patient’s needs.”

Today, approximately 100 leading US surgeons are using the Light Adjustable Lens to deliver outstanding customized vision for their cataract patients. “We are delighted to have partnered with Oxford Finance for additional funding to fuel continued commercial expansion and technology innovations for the premium cataract surgery market,” said Shelley Thunen, chief financial officer at RxSight.

About Oxford Finance LLC

Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $6 billion in loans, with lines of credit ranging from $5 million to $150 million. Oxford is headquartered in Alexandria, Va., with additional offices in San Diego, Calif.; Palo Alto, Calif.; and the greater Boston and New York City areas. For more information, visit https://oxfordfinance.com/

About RxSight, Inc.

RxSight®, Inc., Aliso Viejo, CA is a privately-held, medical technology company focused on the development and commercialization of the world’s first and only adjustable intraocular lens (“IOL”). The RxSight IOL allows optimization of a patient’s vision after lens implantation and healing, using RxSight’s proprietary Light Delivery Device to precisely reshape the implanted lens and achieve a custom prescription for optimal vision outcomes.

Additional information about RxSight can be found at www.rxsight.com.

Contacts

Selma Bašić
Oxford Finance LLC
703-519-4900 Tel
media@oxfordfinance.com

Oxford Finance LLC


Release Summary
Oxford Finance Closes $60 Million Credit Facility with RxSight
Release Versions

Contacts

Selma Bašić
Oxford Finance LLC
703-519-4900 Tel
media@oxfordfinance.com

More News From Oxford Finance LLC

Oxford Finance Strengthens ABL Platform with Appointment of Brock Johnson to Lead Underwriting

ALEXANDRIA, Va.--(BUSINESS WIRE)--Oxford Finance LLC (“Oxford” or the “Company”), a leading specialty finance firm, is pleased to announce the appointment of Brock Johnson to lead Underwriting for its newly created Asset Based Lending (“ABL”) division. In this role, Mr. Johnson will lead the firm’s ABL credit strategy, overseeing deal structuring, credit analysis, and risk management. This key addition strengthens Oxford’s growing ABL platform and reinforces the Company’s commitment to deliveri...

Oxford Finance Appoints Nick McDearis to Lead ABL Originations, Expands into Traditional ABL Market

ALEXANDRIA, Va.--(BUSINESS WIRE)--Oxford Finance LLC (“Oxford” or the “Company”), a leading specialty finance firm, is pleased to announce the appointment of Nick McDearis to lead Asset-Based Lending (ABL) Originations. This strategic hire marks a significant milestone as Oxford enters the traditional ABL market. Nick McDearis brings nearly 20 years of experience in the ABL industry and a proven track record of success in originating and structuring complex financing solutions. His expertise an...

Oxford Finance's Real Estate and ABL Team Achieves Over $715 Million in New Loan Volume in First Half of 2025

ALEXANDRIA, Va.--(BUSINESS WIRE)--Oxford Finance LLC (“Oxford”), a leading specialty finance firm, is pleased to announce its Healthcare Real Estate and Asset-Based Lending (ABL) team closed 10 transactions with new loan commitments of over $715 million during the first half of 2025. This achievement underscores Oxford's commitment to providing innovative and flexible financing solutions to the healthcare industry. The team’s success in the first half of 2025 highlights its ability to adapt to...
Back to Newsroom